MSB is a late-fusion stacking framework for multimodal survival prediction under blockwise missingness that improves C-index over baselines on the PIONeeR lung cancer immunotherapy dataset.
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.AP 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Multimodality Stacking with Blockwise missing values and application to the PIONeeR biomarkers study for prediction of resistance to immunotherapy
MSB is a late-fusion stacking framework for multimodal survival prediction under blockwise missingness that improves C-index over baselines on the PIONeeR lung cancer immunotherapy dataset.